Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Published

Journal Article

The NCCN Guidelines for Survivorship provide screening, evaluation, and treatment recommendations for common physical and psychosocial consequences of cancer and cancer treatment to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period. This portion of the guidelines describes recommendations regarding the management of anthracycline-induced cardiotoxicity and lymphedema. In addition, recommendations regarding immunizations and the prevention of infections in cancer survivors are included.

Full Text

Duke Authors

Cited Authors

  • Denlinger, CS; Sanft, T; Baker, KS; Broderick, G; Demark-Wahnefried, W; Friedman, DL; Goldman, M; Hudson, M; Khakpour, N; King, A; Koura, D; Lally, RM; Langbaum, TS; McDonough, AL; Melisko, M; Montoya, JG; Mooney, K; Moslehi, JJ; O'Connor, T; Overholser, L; Paskett, ED; Peppercorn, J; Pirl, W; Rodriguez, MA; Ruddy, KJ; Silverman, P; Smith, S; Syrjala, KL; Tevaarwerk, A; Urba, SG; Wakabayashi, MT; Zee, P; McMillian, NR; Freedman-Cass, DA

Published Date

  • October 2018

Published In

Volume / Issue

  • 16 / 10

Start / End Page

  • 1216 - 1247

PubMed ID

  • 30323092

Pubmed Central ID

  • 30323092

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

International Standard Serial Number (ISSN)

  • 1540-1405

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2018.0078

Language

  • eng